Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
3.900
+0.050 (1.30%)
Apr 29, 2026, 3:54 PM CST
-41.88%
Market Cap 2.54B
Revenue (ttm) 187.87M
Net Income (ttm) -311.44M
Shares Out 651.90M
EPS (ttm) -0.48
PE Ratio 14.70
Forward PE n/a
Dividend 0.08 (2.04%)
Ex-Dividend Date Jul 15, 2025
Volume 22,358,793
Average Volume 17,103,083
Open 3.810
Previous Close 3.850
Day's Range 3.780 - 3.980
52-Week Range 3.660 - 7.940
Beta 0.47
RSI 31.13
Earnings Date Apr 30, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.